A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences
Tekijät: Rebelos Eleni, Anastasiou Ioanna A., Tentolouris Anastasios, Papanas Nikolaos, Jude Edward
Kustantaja: Sage
Julkaisuvuosi: 2024
Journal: International Journal of Lower Extremity Wounds
Tietokannassa oleva lehden nimi: INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS
Lehden akronyymi: INT J LOW EXTR WOUND
Sivujen määrä: 5
ISSN: 1534-7346
eISSN: 1552-6941
DOI: https://doi.org/10.1177/15347346241233938
Verkko-osoite: https://journals.sagepub.com/doi/10.1177/15347346241233938
Tiivistelmä
Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.
Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.
Turun yliopiston Tutkimustietojärjestelmän portaali